K-numberK250573
Device nameSingle Use Cannula V PR-V223Q/V414Q/V416Q/V418Q/V420Q/V427Q/V434Q/V435Q; Single Use 2-Lumen Cannula V PR-V614M
ApplicantOlympus Medical Systems Corp.
Product codeODD
Device classClass II
Decision dateMay 27, 2025
DecisionSubstantially Equivalent
Regulation876.1500
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Single Use Cannula V and Single Use 2-Lumen Cannula V PR Series are sterile, single-use endoscopic cannulas designed to inject contrast medium into the biliary or pancreatic ducts during endoscopic retrograde cholangiopancreatography (ERCP). Each device has a handle (proximal portion) and an insertion portion with a distal tip optimized for smooth cannulation of the papilla of Vater or minor papilla, and all models are visible under fluoroscopy.

Technological characteristics

The subject devices are sterile single-use cannulas offered with and without stylets and fluoroscopic tips, featuring the same distal tip diameters as predicate devices. Key differences from the predicate are: (1) larger maximum insertion portion diameter (2.0–2.5 mm versus 1.8–2.0 mm), and (2) shorter working length (1700–1950 mm versus 1950–3200 mm). Both subject and predicate devices use ethylene oxide sterilization.

Test standards cited

ISO 10993-1:2018 (biocompatibility), ISO 10993-5:2009 (cytotoxicity), ISO 10993-10:2021 (sensitization), ISO 10993-23:2021 (irritation), ISO 10993-11:2017 (acute systemic toxicity), USP <51> (pyrogenicity), ISO 11135:2014 (sterilization validation), ISO 10993-7:2008 (ethylene oxide residuals), ISO 11607-1:2019 and ASTM F1980-21 (packaging and shelf life).

Substantial equivalence argument

The subject devices share the same intended use, intended patient population (adults), principles of operation, sterilization method, and single-use nature as the predicate ERCP catheters. Although the subject devices have a slightly larger insertion portion diameter and shorter working length, non-clinical mechanical and comparative testing demonstrates these design differences do not raise different questions of safety or effectiveness and do not alter device performance, safety, or efficacy. The devices perform identically in stylet design, tip characteristics, and functional testing (insertion force, contrast infusion, connection strength, visibility).

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →